Pavel Jindra - Concepedia

Author

Pavel Jindra

Also Known As

Alexandra Serris, Jindra Pavel, Jindra, P., Jindra, Pavel, P Jindra, P. JINDRA, P. Jindra, PAVEL JINDRA, Pavel JINDRA, Pavel Jindra

254

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

Charles University Sheba Medical Center Hôpital Saint-Louis Inserm Sorbonne Université

About

Pavel Jindra is an author at Charles University specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	26	1.2K
2	Health Sciences	6	6	283
3	Engineering	3	3	55
4	Public Health	3	3	260
5	Allergy	1	1	14

Pavel Jindra

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation Tomáš Reischig, Pavel Jindra, Ondřej Hes, American Journal of Transplantation UrologyTransplantationCmv DnaemiaKidney TransplantKidney Transplantation	2007	217
Common, intermediate and well‐documented HLA alleles in world populations: CIWD version 3.0.0 Carolyn Katovich Hurley, Jane Kempenich, Kim Wadsworth, HLA HistocompatibilityHlaImmunohematologyHla DiversityGenetics	2020	159
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation Effie W. Petersdorf, Theodore A. Gooley, Mari Malkki, Blood	2014	148
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation F Baron, Myriam Labopin, Didier Blaise, Bone Marrow Transplantation Cell TherapyVivo T-cell DepletionTransplantationMarrow TransplantationMixed-phenotype Acute Leukemia	2014	102
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation Christoph Schmid, Myriam Labopin, Gérard Socié, Blood	2015	101
Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the <scp>A</scp>cute <scp>L</scp>eukemia <scp>W</scp>orking <scp>P</scp>arty of the <scp>E</scp>uropean <scp>G</scp>roup for <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplantation Frédéric Baron, Myriam Labopin, Andy Peniket, Cancer	2014	92
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection Tomáš Reischig, Pavel Jindra, Miroslava Švecová, Journal of Clinical Virology Transplant RejectionTransplantationKidney TransplantKidney TransplantationCytomegalovirus Disease	2006	87
Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis Tomáš Reischig, Pavel Jindra, Ondřej Hes, Transplantation	2009	79
Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT Noga Shem‐Tov, Christophe Peczynski, Myriam Labopin, Leukemia First Complete RemissionCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation	2019	79
Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation Tomáš Reischig, Petra Hřibová, Pavel Jindra, Journal of the American Society of Nephrology UrologyTransplantationKidney TransplantKidney TransplantationProtocol Biopsy Specimen	2012	75

Page 1